SFS
VIR icon

Sowell Financial Services’s Vir Biotechnology VIR Stock Holding History

Sowell Financial Services’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,597
Closed -$66K – 2661
2021
Q1 		$66K Sell
1,597
-1,171
-42% -$63.1K ﹤0.01% 1540
2020
Q4 		$74K Buy
2,768
+226
+9% +$7.35K ﹤0.01% 1268
2020
Q3 		$87K Buy
2,542
+420
+20% +$18.1K ﹤0.01% 1020
2020
Q2 		$87K Buy
+2,122
New +$71.2K ﹤0.01% 1007

Other funds holding VIR

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
APF
Alaska Permanent Fund Juneau, Alaska $1.51B AUM 22.23% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Sowell Financial Services's VIR Position: Q2 2021 in Review

Sowell Financial Services sold out of Vir Biotechnology (VIR) in Q2 2021, closing a stake of 1,597 shares — an estimated $66K sold.

Sowell Financial Services first reported a position in VIR in Q2 2020 and held it in 4 quarters. The position peaked at $87K in Q3 2020. 166 funds tracked by Wall St. Rank hold VIR as of Q2 2021.

  • Sowell Financial Services reported no remaining Vir Biotechnology position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 1,597 Vir Biotechnology shares in Q2 2021, an estimated $66K.
  • Sowell Financial Services first reported a position in Vir Biotechnology in Q2 2020 and held it in 4 quarters.
  • Sowell Financial Services's Vir Biotechnology position peaked at $87K in Q3 2020.
  • 166 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.